Your browser doesn't support javascript.
loading
Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti-tumour necrosis factor alpha.
Marques, E; Arenberger, P; Smetanová, A; Gkalpakiotis, S; Zimová, D; Arenbergerová, M.
Afiliação
  • Marques E; Department of Dermatovenereology, Charles University and Královské Vinohrady University Hospital, Prague, Czech Republic.
  • Arenberger P; Department of Dermatovenereology, Charles University and Královské Vinohrady University Hospital, Prague, Czech Republic.
  • Smetanová A; Department of Dermatovenereology, Charles University and Královské Vinohrady University Hospital, Prague, Czech Republic.
  • Gkalpakiotis S; Department of Dermatovenereology, Charles University and Královské Vinohrady University Hospital, Prague, Czech Republic.
  • Zimová D; Department of Neurology, Third Faculty of Medicine, Charles University and Královské Vinohrady University Hospital, Prague, Czech Republic.
  • Arenbergerová M; Department of Dermatovenereology, Charles University and Královské Vinohrady University Hospital, Prague, Czech Republic.
Br J Dermatol ; 184(5): 966-967, 2021 05.
Article em En | MEDLINE | ID: mdl-33301601

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidradenite Supurativa Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidradenite Supurativa Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article